INTRODUCTION
Activators of protein kinase C (PKC), including phorbol 12-myristate 13-acetate (PMA) [1, 2] , 1,2-diacylglycerol-elevating hormones [3] and exogenous phospholipase C [4] , commonly stimulate phospholipase D (PLD)-mediated hydrolysis of both phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn). Most recent evidence suggests that the effects of PKC activators on PLD activity are mediated by PKC, although a protein-phosphorylation step may not be involved [5] .
Recent studies also established PKC as a zinc-binding protein [6] [7] [8] [9] [10] [11] [12] [13] . Four atoms of zinc bind tightly to the regulatory domain of PKC, which appears to be a requirement for the binding of phorbol ester to this region [13] . As a consequence, the zinc status of PKC affects phorbol-ester-induced redistribution of this enzyme in cells [6, 8, 10] . In intact cells, phorbol-ester-induced membrane translocation of PKC was shown to be reversed by the high-affinity zinc-specific chelator 1, 10-phenanthroline, indicating that membrane-bound PKC is regulated by a chelatable cellular zinc pool [11] . Accordingly, one would expect that 1,10-phenanthroline will inhibit phorbol ester stimulation of PLD. The present work was initiated to examine this possibility. I found that in NIH 3T3 fibroblasts 1, 10-phenanthroline enhanced, rather than inhibited, the stimulatory effect of PMA and plateletderived growth factor (PDGF) on PLD activity. In addition, phenanthroline also enhanced the stimulatory effect of staurosporine, which was shown to stimulate PLD activity by a PKCindependent mechanism [14] . These results indicate that in fibroblasts a chelatable pool of zinc negatively influences regulation of PLD activity by PKC activators and staurosporine. also enhanced the stimulatory effect of PMA on the synthesis of phosphatidylethanol, a marker of PLD activity. Addition of zinc (250 ,#M) to phenanthroline-treated fibroblasts reversed the stimulatory effects of the chelator. The potentiating effects of phenanthroline were also partially reversed by cadmium, whereas iron, lead, copper, magnesium and calcium were without effects. Of the other activators of PLD tested, phenanthroline also enhanced the stimulatory effects of platelet-derived growth factor and staurosporine, but not that of sphingosine and H202, on the hydrolysis of both phospholipids. These results suggest that regulation of PLD [6] ), an additional 20 min incubation period between scraping and centrifugation (10 min at 500 g) was inserted. A 30 min period is needed for the return of cellular 1 ,2-diacylglycerol to the control level [16] . At this step, about 95 % of cells were viable, determined by the Trypan Blue dye exclusion assay. Scraped cells retained sensitivity to activators of PLD, including PMA [1,2], 1,2-diacylglycerol-elevating hormones [3] , sphingosine [17, 18] and staurosporine [18] . Portions (0.2 ml) of cell suspension [(1.6-2.0) x 106 cells/ml] were incubated (final volume 0.25 ml) in the presence of unlabelled choline (20 mM) or ethanolamine (2 mM) (to prevent further metabolism of newly formed '4C-labelled bases [1, 15] ). Fractionation of choline and ethanolamine metabolites was performed on Dowex-50W (H+)-packed columns (Bio-Rad Econo-columns; 1 ml bed volume) as described by Cook and Wakelam [19] for the choline derivatives with some modifications. The initial flow-through (4.5 ml) along with a following 3.5 ml or 5 ml water wash contained glycerophosphoethanolamine or glycerophosphocholine, respectively. Ethanolamine phosphate and choline phosphate were eluted by 15 ml and 20 ml of water, respectively. Finally, ethanolamine and choline were eluted by 12 ml and 20 ml of 1 M HCI, respectively. The metabolites of [14C]ethanolamine and [14C]choline were further identified by t.l.c. [1] . In previous studies we determined that, under these conditions, formation of [14C]choline and [14C]ethanolamine is due to PLD activity [1] . Phospholipids were separated as described previously [20] . .r-l concentrations of iron (Fe3+ ions), lead, copper, magnesium and calcium had no such effects (results not shown).
RESULTS

Effects
Since dissociation of zinc from zinc-binding proteins is likely to be slow [13] , significant depletion ofthe total cellular (including protein-bound) zinc pool may require longer treatments with 1,10-phenanthroline. Thus, in principle, increasing the time of treatment may result in greater potentiating effects of 1,10-phenanthroline. To (Figure 3b ). These differences in the effects of zinc chelator on the hydrolysis of PtdEtn and PtdCho were highly reproducible (four experiments were performed).
It has been shown previously [6] that treatment of rabbit thymocytes with 20 nM PMA for 90 min resulted in intracellular redistribution of zinc. A similarly slow PMA-induced redistribution of zinc from the site of PtdEtn hydrolysis to other intracellular sites might explain why 1, 10-phenanthroline failed to enhance the effects of 20-100 nM PMA on PtdEtn hydrolysis after 60 min treatment. However, if such a mechanism indeed operates in fibroblasts, then restoration of zinc in 'PMAsensitive' intracellular pool(s) by externally added zinc should lead to an inhibition of PtdEtn hydrolysis induced by higher concentrations of PMA. To test if this might be the case, the effects of 250 ,uM zinc on PtdEtn hydrolysis, induced by various concentrations of PMA for 60 min, were next examined. As shown in Figure 4 , zinc had no significant effect on PtdEtn hydrolysis in the presence of low concentrations (3-10 nM) of PMA, whereas it significantly inhibited the stimulatory effects of higher concentrations (20- Effect of 1,10-phenanthroline on phospholipid hydrolysis in the presence of other stimulators of PLD In NIH 3T3 fibroblasts, hormonal activators of PKC, such as PDGF and bombesin, also increase the rate of hydrolysis of both PtdCho and PtdEtn [3] . In addition to PKC activators, PLDmediated hydrolysis of these phospholipids is also commonly elicited by sphingosine [17, 18] , H202 [21] and staurosporine [14, 18] . To define better the site of action of 1, 10-phenanthroline, I next examined the combined effects of this chelator and the above PLD stimulat.)rs. As shown in Table 1 , 1,10-phenanthroline significantly enhanced the stimulatory effects of PDGF on the hydrolysis of both PtdCho and PtdEtn, whereas it failed to modify the stimulatory effects of both sub-optimal and optimal concentrations of sphingosine and H202' It should be emphasized here that the length of incubation time (20 min) was optimal for the effects of these PLD stimulators.
In contrast with the above stimulators of PLD, the optimal incubation time for the stimulatory effect of staurosporine on phospholipid hydrolysis was about 40 min, as determined in preliminary time-course experiments (results not shown). During this incubation time, 1 mM 1,10-phenanthroline significantly (1.5-2.1-fold) enhanced the stimulatory effects of both suboptimal (2 ,uM) and optimal (5 ,uM) concentrations of staurosporine on PLD-mediated hydrolysis of PtdCho and PtdEtn ( Table 2) . Addition of 250 ,uM zinc to fibroblasts pretreated with 1 mM phenanthroline for 30 min also reversed the potentiating effect (1.6-1.8-fold) of chelator on staurosporine (5 ,uM)-induced phospholipid hydrolysis (results not shown).
DISCUSSION
The major finding of this work is that 1,10-phenanthroline, a high-affinity zinc chelator, potentiated, rather than inhibited, the stimulatory effects of PKC activators PMA and PDGF on PLD activity. The potentiating effects of 1,10-phenanthroline were reversed by zinc and to a lesser extent by cadmium, but not by other metals. At the present, I cannot exclude the possibility that some of these metals (in particular, iron, lead and copper) were ineffective because of their poor cellular uptake. The inhibitory effect of zinc was unexpected because zinc has a positive influence on PKC activity [6] [7] [8] [9] [10] [11] [12] [13] , and because PKC appears to mediate the stimulatory effect of PMA on PLD activity [5] . There are three possible mechanisms which may account for the observed potentiating effects of 1,10-phenanthroline and for the inhibitory effects of zinc.
The first possibility is that a chelatable cellular pool of zinc directly inhibits PLD activity, whereas PKC is regulated by tightly bound (non-chelatable) zinc. In this case, 1,10-phenanthroline would act at the level of PLD, and would be expected to inhibit the effect of any PLD activator. However, 1,10-phenanthroline clearly failed to enhance the stimulatory effects of both sub-optimal and optimal concentrations of sphingosine and H202. For this reason, direct inhibition of PLD (which, in fact, has very low activity in unstimulated cells) by zinc is unlikely.
The second possibility is that the effect of PMA on PLD activity is mediated by a PKC-independent protein which (in contrast with PKC) is inhibited by a chelatable cellular pool of zinc. Although it may be argued that more evidence is required to establish firmly the role of PKC in the regulation of PLD, no evidence has yet been presented against such role of PKC. Thus, although not totally impossible, presently available experimental evidence [5] disfavours the role of a zinc-inhibitable non-PKC protein in the mediation of PMA effect on PLD activity.
The third, and the most likely, possibility is that regulation of PLD activity by activated PKC occurs by a multiple-step process, and one of the intermediate stimulatory steps is inhibited by zinc. Work from several laboratories established synergistic interaction between the activators of PKC and G-proteins on the stimulation of PLD activity [22] [23] [24] [25] . In addition, the action of staurosporine on PLD also appears to involve a G-protein [14] . Thus it is quite possible that, in NIH 3T3 fibroblasts as well, a Gprotein is involved in the mediation, or at least in the potentiation, of phorbol ester effects on PLD activity. In fact, we have previously shown [2] that in membranes from Ha-ras-or v-raftransformed NIH 3T3 fibroblasts PMA can significantly stimulate PLD activity only in the concomitant presence of ATP and a hydrolysis-resistant analogue of GTP. Based on this evidence, we have started investigating the possibilities that zinc inhibits either GTP activation of PLD, or the interaction between the PKC and GTP-binding proteins involved in the regulation of PLD. Preliminary results indicate that in isolated membranes [17] stimulation of PLD by stable GTP analogues is not significantly enhanced by 1,10-phenanthroline. Thus it seems more likely either that zinc inhibits interaction between PKC and a regulatory G-protein, or that the action of phorbol ester on PLD depends, in addition to PKC, on a presently unknown factor. Clearly, understanding of the exact mechanism of phorbol ester action on PLD is an important prerequisite for a precise determination of the site of inhibitory zinc action.
In fibroblasts, nearly all activators of PLD examined so far, including PMA [1, 2] , PKC-activating hormones [3] , nucleotides [17] , sphingosine [17, 18] and staurosporine (the present work), stimulate the hydrolysis of both PtdCho and PtdEtn. The only exceptions are alcohols, which stimulate only PtdEtn hydrolysis, and do so in a strictly PKC-dependent manner [26] . In the present work, at a longer incubation time (60 min), phenanthroline enhanced the hydrolysis of only PtdCho, but not PtdEtn, at optimal (100 nM) or near-optimal (20 nM) concentrations of PMA. Conversely, at this incubation time (60 min) added zinc inhibited only the hydrolysis of PtdEtn, but not PtdCho, in the presence of higher concentrations (20-100 nM) of PMA. The exact reason(s) for the observed differences between the effects of zinc on PtdEtn and PtdCho hydrolysis is not known. However, it has been reported previously [6] that PMA can induce slow intracellular redistribution of zinc. Thus it is possible that in fibroblasts PMA can deplete a chelatable zinc pool which specifically regulates PtdEtn hydrolysis. Such process would (i) result in a maximal stimulation of PtdEtn hydrolysis by PMA, (ii) diminish the potentiating effect of 1, 10-phenanthroline, and (iii) sensitize the PtdEtn-hydrolysing system to the inhibitory effect of added zinc. Although our results are in agreement with these predictions, further experiments are required to determine that PMA indeed induces redistribution of zinc in fibroblasts and that this specifically correlates with altered regulation of PtdEtn hydrolysis by PMA.
Regardless of the exact mechanism(s) by which 1,10-phenanthroline and zinc acted, these observations indicate that the PtdCho-and PtdEtn-hydrolysing systems are somewhat differentially regulated by zinc. This may reflect the existence of separate PLD enzyme systems, acting on PtdCho and PtdEtn with some selectivity, which may be differentially sensitive to the inhibitory effect of zinc. In addition, these phospholipases may catalyse the hydrolysis of PtdCho and PtdEtn in different subcellular compartments which contain different levels of chelatable zinc. Recent data, indicating that most cell types express two different PLD molecules hydrolysing either PtdEtn and/or PtdCho [27] , could provide a basis for the observed differential effects of zinc on phospholipid hydrolysis. However, further experiments are required to prove that fibroblasts indeed express different, PtdCho-and PtdEtn-specific, PLD activities.
In summary, I showed that, despite the positive effect of zinc on the PKC system, a chelatable cellular pool of zinc inhibits, rather than potentiates, the stimulatory effects of PMA, PDGF and staurosporine on PLD-mediated hydrolysis of PtdCho and PtdEtn. The results suggest that the inhibitory effects of zinc are not due to its direct interaction with PLD 
